EKSO vs. TPIC, TRSG, SHMD, FTEK, INLF, TRT, LBGJ, CVV, ZOOZ, and GTEC
Should you be buying Ekso Bionics stock or one of its competitors? The main competitors of Ekso Bionics include TPI Composites (TPIC), Tungray Technologies (TRSG), SCHMID Group (SHMD), Fuel Tech (FTEK), INLIF (INLF), Trio-Tech International (TRT), Li Bang International (LBGJ), CVD Equipment (CVV), ZOOZ Power (ZOOZ), and Greenland Technologies (GTEC). These companies are all part of the "machinery" industry.
Ekso Bionics vs.
Ekso Bionics (NASDAQ:EKSO) and TPI Composites (NASDAQ:TPIC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, community ranking, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.
In the previous week, Ekso Bionics and Ekso Bionics both had 3 articles in the media. Ekso Bionics' average media sentiment score of 0.96 beat TPI Composites' score of 0.41 indicating that Ekso Bionics is being referred to more favorably in the media.
Ekso Bionics has higher earnings, but lower revenue than TPI Composites. Ekso Bionics is trading at a lower price-to-earnings ratio than TPI Composites, indicating that it is currently the more affordable of the two stocks.
TPI Composites received 31 more outperform votes than Ekso Bionics when rated by MarketBeat users. Likewise, 63.69% of users gave TPI Composites an outperform vote while only 54.44% of users gave Ekso Bionics an outperform vote.
TPI Composites has a net margin of -18.01% compared to Ekso Bionics' net margin of -62.95%. TPI Composites' return on equity of 0.00% beat Ekso Bionics' return on equity.
Ekso Bionics presently has a consensus target price of $5.00, suggesting a potential upside of 1,039.73%. TPI Composites has a consensus target price of $3.19, suggesting a potential upside of 274.22%. Given Ekso Bionics' stronger consensus rating and higher possible upside, research analysts clearly believe Ekso Bionics is more favorable than TPI Composites.
Ekso Bionics has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Comparatively, TPI Composites has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500.
6.4% of Ekso Bionics shares are held by institutional investors. Comparatively, 75.2% of TPI Composites shares are held by institutional investors. 6.1% of Ekso Bionics shares are held by insiders. Comparatively, 3.7% of TPI Composites shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
TPI Composites beats Ekso Bionics on 10 of the 18 factors compared between the two stocks.
Get Ekso Bionics News Delivered to You Automatically
Sign up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Ekso Bionics Competitors List
Related Companies and Tools
This page (NASDAQ:EKSO) was last updated on 3/28/2025 by MarketBeat.com Staff